Source: FORT MILL TIMES

Sapheon: Sapheon Announces One Year Follow-Up Data in European Multicenter Clinical Study

Sapheon Inc. announced one year data in its European multicenter clinical study of the VenaSeal® Sapheon Closure System. VenaSeal is an advanced approach to the treatment of venous reflux (varicose…Click to Continue »

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Don Crawford's photo - Founder & CEO of Sapheon

Founder & CEO

Don Crawford

CEO Approval Rating

70/100

Read more